Medical Writing Market

Executive Summary

Medical Writing Market was valued at US $3.97 billion in 2021 and is projected to grow at 10.97% CAGR over the forecast period to reach US $7.42 billion by 2027. Medical Writing Market represented US $0.75 billion opportunity over 2019-2021 and estimated to create US $3.45 billion opportunity in 2027 over 2021.

Medical Writing from Consainsights analyses the Medical Writing Market in the Life Sciences industry over the forecast period to 2027.

Medical Writing research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Medical Writing segmentation includes Type, Application, End Use and Geography.

Based on the Type, the Medical Writing analysis covers Clinical Writing, Regulatory Writing, Scientific Writing, Others.

In Type segment, Clinical Writing segment has highest cagr growth of 9.69%.

Based on the Application, the Medical Writing analysis covers Medico Marketing, Medical Education, Medical Journalism, Others.

In Application segment, Medico Marketing segment has highest cagr growth of 9.69%.

Based on the End Use, the Medical Writing analysis covers Contract Research Organizations (CROs) & Others, Medical Device/Pharmaceutical & Biotechnologynology Companies.

In End Use segment, Contract Research Organizations (CROs) & Others segment has highest cagr growth of 9.69%.

Based on the region, the Medical Writing analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include FREYR, QUANTICATE, InClin, Inc., Synchrogenix, Covance, Inc., IQVIA HOLDINGS INC., OMICS International, Cactus Communications, SIRO Clinpharm Private Limited, Parexel International Corporation, Trilogy Writing & Consulting GmbH and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Type

Introduction

In 2021, Clinical Writing segment has the highest revenue of US $1.43 billion and is expected to grow at CAGR of 9.69% by 2027 Clinical Writing segment has highest cagr growth of 9.69%.

Clinical Writing

Clinical Writing segment was valued at US $1.16 billion in 2019 and is projected to grow at 9.69% CAGR over the forecast period to reach US $2.66 billion by 2027. Clinical Writing segment represented US $0.27 billion opportunity over 2019-2021 and estimated to create US $1.24 billion opportunity in 2027 over 2021.

Regulatory Writing

Regulatory Writing segment was valued at US $1.03 billion in 2019 and is projected to grow at 9.69% CAGR over the forecast period to reach US $2.37 billion by 2027. Regulatory Writing segment represented US $0.24 billion opportunity over 2019-2021 and estimated to create US $1.10 billion opportunity in 2027 over 2021.

Scientific Writing

Scientific Writing segment was valued at US $0.78 billion in 2019 and is projected to grow at 9.69% CAGR over the forecast period to reach US $1.80 billion by 2027. Scientific Writing segment represented US $0.18 billion opportunity over 2019-2021 and estimated to create US $0.84 billion opportunity in 2027 over 2021.

Others

Others segment was valued at US $0.25 billion in 2019 and is projected to grow at 9.69% CAGR over the forecast period to reach US $0.58 billion by 2027. Others segment represented US $0.06 billion opportunity over 2019-2021 and estimated to create US $0.27 billion opportunity in 2027 over 2021.

Application

Introduction

In 2021, Medico Marketing segment has the highest revenue of US $2.07 billion and is expected to grow at CAGR of 9.69% by 2027 Medico Marketing segment has highest cagr growth of 9.69%.

Medico Marketing

Medico Marketing segment was valued at US $1.68 billion in 2019 and is projected to grow at 9.69% CAGR over the forecast period to reach US $3.87 billion by 2027. Medico Marketing segment represented US $0.39 billion opportunity over 2019-2021 and estimated to create US $1.80 billion opportunity in 2027 over 2021.

Medical Education

Medical Education segment was valued at US $0.92 billion in 2019 and is projected to grow at 9.69% CAGR over the forecast period to reach US $2.11 billion by 2027. Medical Education segment represented US $0.21 billion opportunity over 2019-2021 and estimated to create US $0.98 billion opportunity in 2027 over 2021.

Medical Journalism

Medical Journalism segment was valued at US $0.40 billion in 2019 and is projected to grow at 9.69% CAGR over the forecast period to reach US $0.91 billion by 2027. Medical Journalism segment represented US $0.09 billion opportunity over 2019-2021 and estimated to create US $0.42 billion opportunity in 2027 over 2021.

Others

Others segment was valued at US $0.23 billion in 2019 and is projected to grow at 9.69% CAGR over the forecast period to reach US $0.52 billion by 2027. Others segment represented US $0.05 billion opportunity over 2019-2021 and estimated to create US $0.24 billion opportunity in 2027 over 2021.

End Use

Introduction

In 2021, Contract Research Organizations (CROs) & Others segment has the highest revenue of US $2.23 billion and is expected to grow at CAGR of 9.69% by 2027 Contract Research Organizations (CROs) & Others segment has highest cagr growth of 9.69%.

Contract Research Organizations (CROs) & Others

Contract Research Organizations (CROs) & Others segment was valued at US $1.81 billion in 2019 and is projected to grow at 9.69% CAGR over the forecast period to reach US $4.16 billion by 2027. Contract Research Organizations (CROs) & Others segment represented US $0.42 billion opportunity over 2019-2021 and estimated to create US $1.93 billion opportunity in 2027 over 2021.

Medical Device/Pharmaceutical & Biotechnologynology Companies

Medical Device/Pharmaceutical & Biotechnologynology Companies segment was valued at US $1.42 billion in 2019 and is projected to grow at 9.69% CAGR over the forecast period to reach US $3.26 billion by 2027. Medical Device/Pharmaceutical & Biotechnologynology Companies segment represented US $0.33 billion opportunity over 2019-2021 and estimated to create US $1.52 billion opportunity in 2027 over 2021.